slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 10,921-10,950
Pages 819
Rows per page 30
Slide function
10,921-10,950 of 24,547
16
The slide uses a visual mapping of hardware platforms to specific assay portfolios.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank Beat · Solution1 hit
09
Uses a 'Before-After' framing for each of the six points.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a 2x2 grid layout to categorize stakeholder benefits, followed by a horizontal process flow at the bottom.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Beat · Business ModelLoop · Cost Of Inaction1 hit
12
Uses a waterfall chart to illustrate unit economics.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
13
The slide uses a process flow diagram to illustrate the care delivery model, supported by a proprietary platform called 'Canopy'.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide uses a numbered list format to explain the technical architecture.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
Uses a three-part chevron process flow to illustrate the transition from market problem to clinical results to financial performance.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
06
The slide uses a modular framework to categorize the company's technological stack.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
07
The diagram illustrates the 'cut and paste' mechanism of the transposon system.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a visual metaphor of combining two existing technologies to create a superior third one.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
09
The slide uses a spectrum-style diagram to categorize delivery methods.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
13
The slide uses a process diagram to show cell differentiation and a callout box to list clinical benefits.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Cost Of Inaction1 hit
14
Poseida Therapeutics | IPO Presentation Deck | 34 slidesPoseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Cost Of Inaction1 hit
17
Includes a process flow diagram and a specific technical callout for Cas-CLOVER gene editing.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
18
The slide uses a biological diagram to explain the mechanism of T-cell activation and a line chart to show the performance improvement.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
19
The slide uses two distinct chart types (bar and dot plot) to highlight two key performance metrics of the technology.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
22
Uses a before-after framing to contrast standard multi-dose therapy with the company's single-dose, self-renewing approach.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
25
The slide uses a combination of a table for market potential, a biological diagram for mechanism, and bar charts for efficacy and safety.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
27
The slide highlights the technical advantage of the piggyBac system in delivering multiple genes for multi-target CAR-T therapies.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
29
The slide uses a two-column layout to contrast technical capability (PiggyBac) with market breadth (indications).Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
30
The slide contrasts the persistence of integrated transposons versus the clearance of non-integrated AAV following liver cell replication.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
32
The slide uses a comparative framework to show the efficacy of the non-viral approach.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
33
The slide uses a modular layout to categorize the company's technology platforms and therapeutic pipeline.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
07
The background is a repeating pattern of chemical structures. The central image is a protein model.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a Venn diagram to show the intersection of Experimentation and Computation.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
13
Uses a visual comparison framework to illustrate the superiority of their proprietary technology in protein visualization.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
14
Includes preclinical data comparing RLY-4008 to Pemigatinib, Infigratinib, and TAS-120.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
16
The slide uses a before-after framing: the left side shows the biological problem (pathway signaling), and the right side shows the solution (a library of optimized compound designs).Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
17
Waterfall plots showing tumor volume change in xenograft models.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
10
The slide uses a matrix-like structure to contrast two business models across operating characteristics and geographic presence.Rush Street | SPAC Presentation Deck | 37 slides · Rush Street Interactive
Pitch deck Investment bank 1 hit